Skip to main content
Jinying Zhou on Muck Rack

Jinying Zhou

As seen in: Nature, MDPI, Genome Medicine, Dove Medical Press, JACC (Journal of the American College of Cardiology), Canadian Journal of Cardiology, The Tullahoma News, Citizen Tribune, International Journal of Cardiology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jinying

Contact Jinying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Age-related loss of Y chromosome is associated with mortality after ST-segment elevation myocardial infarction

|
By Nan Li, Jiannan Li, Yu Jun Tan, Runzhen Chen, Xiaoxiao Zhao, Peng Zhou, Chen Liu, Jinying Zhou, Yi Chen, Shaodi Yan, Hanjun Zhao, Hongbing Yan
| Nature Verified
Abstract While loss of Y chromosome (LOY), a common somatic alteration with aging, has been associated with cardiovascular diseases, its specific impact on ST-segment elevation myocardial infarction (STEMI) remains underexplored. This study enrolled 928 males undergoing primary percutaneous coronary intervention for STEMI to investigate the impact of LOY in blood cells on all-cause mortality. LOY was measured in males using droplet digital polymerase chain reaction technique.
Open in Who Shared Issue with article?

Effect of clonal hematopoiesis on plaque morphology and prognosis in patients with acute myocardial infarction - Genome Medicine

|
By Jiannan Li, Runzhen Chen, Jinying Zhou, Nan Li, Peng Zhou, Chen Liu, Xiaoxiao Zhao, Yi Chen, Shaodi Yan, Hongbing Yan, Yu Ann Tan, Hanjun Zhao
| Genome Medicine Verified
This prospective cohort study was conducted in a large-volume national tertiary care institute (Fuwai Hospital, Beijing) specializing in cardiovascular diseases. Between March 2017 and January 2020, 1403 patients (age ≥ 18 years) who underwent emergent coronary angiography and CHIP examinations due to the diagnosis of STEMI (symptom onset ≤ 24 h before presentation) were prospectively enrolled.
Open in Who Shared Issue with article?

A Prospective Study Assessing the Clinical Utility of Novel Lipid Para

|
By Xiaoxiao Zhao, Runzhen Chen, Jiannan Li, Jinying Zhou
| Dove Medical Press
Introduction Current guidelines from the American Heart Association/American Stroke Association (2018) emphasize intensive lipid-lowering therapy for the secondary prevention of ischemic stroke of atherosclerotic origin following transient ischemic attack (TIA) or ischemic stroke.1,2 Despite these established recommendations, residual cardiovascular risk remains substantial, particularly among patients with concurrent metabolic diseases.
Open in Who Shared Issue with article?
See all 11 articles